Overview
Melodi Javid Whitley, MD, PhD
Assistant Professor of Dermatology
Assistant Program Director for Trainee Research
Director of Transplant Dermatology
I am a physician scientist focused on the dermatologic care of solid organ transplant recipients. Clinically, I manage the the complex dermatologic side effects of immunosuppression with a focus on high-risk skin cancer. My research focuses on understanding the drivers of cutaneous malignancy in this population using translational approaches.
Assistant Professor of Dermatology
Assistant Program Director for Trainee Research
Director of Transplant Dermatology
I am a physician scientist focused on the dermatologic care of solid organ transplant recipients. Clinically, I manage the the complex dermatologic side effects of immunosuppression with a focus on high-risk skin cancer. My research focuses on understanding the drivers of cutaneous malignancy in this population using translational approaches.
Current Appointments & Affiliations
Assistant Professor of Dermatology
·
2022 - Present
Dermatology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2023 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Delayed Time to First Skin Cancer Among Hematopoietic Stem Cell Transplant Recipients With Chronic Cutaneous Graft-Versus-Host Disease
Journal Article JEADV Clinical Practice · March 1, 2026 Background: Hematopoietic stem cell transplant (HSCT) recipients face an increased risk of cutaneous malignancies. Chronic cutaneous graft-versus-host disease (cGVHD), specific to allogeneic HSCT (alloHSCT), has been proposed to further elevate this risk, ... Full text CiteCurrent landscape of AI Regulation in Dermatology.
Journal Article J Am Acad Dermatol · March 2026 Full text Link to item CiteIchthyosiform sarcoidosis with associated calcinosis cutis and cardiac arrest
Journal Article Jaad Case Reports · February 1, 2026 Full text CiteRecent Grants
Philogen 2L sSCC / PH-L19IL2TNFSCC
Clinical TrialPrincipal Investigator · Awarded by Philogen S.p.A · 2026 - 2030Philogen BCC COMB / PH-L19IL2TNFCOMB
Clinical TrialPrincipal Investigator · Awarded by Philogen S.p.A · 2026 - 2030View All Grants
Education
Duke University, School of Medicine ·
2017
M.D.
Duke University, School of Medicine ·
2017
Ph.D.